Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Increased risk of bladder cancer in young adult men with hyperlipidemia: A population-based cohort study.
Risk of bladder cancer significantly higher in men aged 20 to 39 years in hyperlipidemia cohort.
»
05/20/20
BRAF Inhibitors Reprogram Cancer-Associated Fibroblasts to Drive Matrix Remodeling and Therapeutic Escape in Melanoma.
POSTN activates phosphoinositide 3-kinase (PI3K)/AKT signaling and subsequently reactivates ERK pathway.
»
02/23/21
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Protective effect of oral contraceptives and implants on risk of ovarian cancer.
»
11/03/21
Use of Neoadjuvant Chemotherapy in Elderly Patients With Muscle-Invasive Bladder Cancer: A Population-Based Study, 2006-2017.
Elderly patients receiving NAC and RC had improved perioperative outcomes.
»
01/28/22
Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer.
Elevated LDH at 6 weeks associated with significantly shorter OS.
»
12/26/21
Resveratrol and Cervical Cancer: A New Therapeutic Option?
New generation of drugs, herbs and spices afford novel opportunities for cancer therapy.
»
08/23/21
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018.
Glioma patients with postoperative epilepsy had increased risk of death.
»
10/21/21
Genome-wide association analyses identify CATSPERE as a mediator of colorectal cancer susceptibility and progression.
CATSPERE exerted pleiotropic effects.
»
01/18/22
Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients.
Mean Ki67% reduction at 2 weeks was significantly higher for patients receiving abemaciclib plus anastrozole.
»
10/25/21
Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
Patient and tumor characteristics may be used to stratify patients.
»
09/12/21
< Prev
Next >